Glutamate metabolizing enzymes in prefrontal cortex of Alzheimer's disease patients

Neurochemical Research

Volumn 30, Issue 11, 2005, Pages 1443-1451

  Burbaeva, Gulnur Sh ^a   Boksha, Irina S ^a   Tereshkina, Elena B ^a   Savushkina, Olga K ^a   Starodubtseva, Lubov I ^a   Turishcheva, Marina S ^a  

^a MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

Author keywords

Alzheimer disease; Autopsied brain; Control brain; Creatine phosphokinase; Cytoplasm; ECL Western immunoblotting; Energy metabolism; Glutamate dehydrogenase; Glutamate metabolism; Glutamine synthetase; Glutamine synthetase like protein; Immunoreactivity

Indexed keywords

ENZYME; GLUTAMATE AMMONIA LIGASE; GLUTAMATE DEHYDROGENASE; GLUTAMATE DEHYDROGENASE I; GLUTAMATE DEHYDROGENASE II; GLUTAMATE DEHYDROGENASE III; GLUTAMIC ACID; GLUTAMINASE; GLUTAMINE SYNTHETASE LIKE PROTEIN; ISOENZYME; PHOSPHATE ACTIVATED GLUTAMINASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BRAIN; BRAIN TISSUE; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME ISOLATION; ENZYME METABOLISM; HUMAN; HUMAN TISSUE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; WESTERN BLOTTING;

AGED; ALZHEIMER DISEASE; AMIDE SYNTHASES; FEMALE; GLUTAMATE DEHYDROGENASE; GLUTAMATE-AMMONIA LIGASE; GLUTAMIC ACID; GLUTAMINASE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; PREFRONTAL CORTEX; STATISTICS; TISSUE EXTRACTS;

EID: 28944452947     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-005-8654-x     Document Type: Article

References (28)

1. J. T. Greenamyre W. R. Maragos R. L. Albin J. B. Penney A. B. Johng 1988 Glutamate transmission and toxicity in Alzheimer's disease Prog. Neuropsychopharmacol. Biol. Psychiatr. 12 421 430
2. 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia Neurol. Res. 26 5 488 495
3. N. B. Farber X. P. Jiang C. Heinkel B. Nemmers 2002 Antiepileptic drugs and agents that inhibit voltage-gated sodium channels prevent NMDA antagonist neurotoxicity Mol. Psychiatr. 7 7 726 733
4. M. R. Hynd H. L. Scott P. R. Dodd 2004 Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease Neurochem. Int. 45 5 583 595
5. A. J. Mishizen-Eberz R. A. Rissman T. L. Carter M. D. Ikonomovic B. B. Wolfe D. M. Armstrong 2004 Biochemical and molecular studies of NMDA receptor subunits NR1/2A/2B in hippocampal subregions throughout progression of Alzheimer's disease pathology Neurobiol. Dis. 15 1 80 92
6. H. G. Lee O. Ogawa X. Zhu M. J. O'Neill R. B. Petersen R. J. Castellani H. Ghanbari G. Perry M. A. Smith 2004 Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer's disease Acta Neuropathol. (Berl) 107 4 365 371
7. H. Bleich S. Romer H. Wiltfang J. M. Kornhuber 2003 Glutamate and the glutamate receptor system: A target for drug action Int. J. Geriatr. Psychiatr. 18 Suppl.1 S33 S40
8. C. G. Parsons W. Danysz G. Quack 1999 Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - A review of preclinical data Neuropharmacology 38 735 767
9. D. A. Butterfield C. B. Pocernich 2003 The glutamatergic system and Alzheimer's disease: Therapeutic implications CNS Drugs 17 9 641 652
10. S. Li M. Mallory M. Alford 1997 Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression J. Neuropathol. Exp. Neurol. 56 901 911
11. A. W. Procter A. M. Palmer P. T. Francis 1988 Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease J. Neurochem. 50 790 802
12. H. Akiyama P. L. [tmp] McGeer S. Itagaki E. G. [tmp] McGeer T. Kaneko 1989 Loss of glutaminase-positive cortical neurons in Alzheimer's disease Neurochem. Res. 14 4 353 358
13. F. Boissiere B. Faucheux C. Duyckaerts J. J. Hauw Y. Agid E. C. Hirsch 1998 Striatal expression of glutamic acid decarboxylase gene in Alzheimer's disease J. Neurochem. 71 2 767 774
14. S. R. Robinson 2000 Neuronal expression of glutamine synthetase in Alzheimer's disease indicates a profound impairment of metabolic interactions with astrocytes Neurochem. Int. 36 4-5 471 482
15. D. Gunnersen B. Haley 1992 Detection of glutamine synthetase in the cerebrospinal fluid of Alzheimer diseased patients: A potential diagnostic biochemical marker Proc. Natl. Acad. Sci. USA 89 24 11949 11953
16. H. Tumani G. Q. Shen J. B. Peter 1995 Purification and immunocharacterization of human brain glutamine synthetase J. Immunol. Methods 188 155 163
17. M. Takahashi E. Stanton J. I. Moreno G. Jackowski 2002 Immunoassay for serum glutamine synthetase in serum: Development, reference values, and preliminary study in dementias Clin. Chem. 48 375 378
18. G. Sh. Burbaeva M. S. Turishcheva E. B. Vorobyeva O. K. Savushkina E. B. Tereshkina I. S. Boksha 2002 Diversity of glutamate dehydrogenase in human brain Prog. Neuropsychopharmacol. Biol. Psychiatr. 26 3 427 435
19. I. S. Boksha E. B. Tereshkina G. Sh. Burbaeva 2000 Glutamine synthetase and glutamine synthetase-like protein from human brain: Purification and comparative characterization J. Neurochem. 75 2574 2582
20. I. S. Boksha H.-J. Schönfeld H. Langen F. Müller E. B. Tereshkina G. Sh. Burbaeva 2002 Glutamine synthetase isolated from human brain: Octameric structure and homology of partial primary structure with human liver glutamine synthetase Biochemistry 67 9 1012 1020 Moscow
21. D. Shin C. Park 2004 N-terminal extension of canine glutamine synthetase created by splicing alters its enzymatic property J. Biol. Chem. 279 2 1184 1190
22. G. Sh. Burbaeva I. S. Boksha M. A. Morozova L. I. Starodubtseva E. B. Tereshkina 2005 Platelet glutamine synthetase-like protein as a predictor of olanzapine efficacy in schizophrenia World J. Biol. Psychiatr. 6S1 249 250
23. U. Laemmli 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 680 685
24. H. Towbin T. Staehelin J. Gordon 1979 Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets, procedure and some applications Proc. Natl. Acad. Sci. USA 76 4350 4354
25. O. H. Lowry N. J. Rosenbrough A. L. Farr R. J. Randall 1951 Protein measurement with the Folin Phenol Reagent J. Biol. Chem. 193 265 275
26. G. Sh. Burbaeva O. K. Savushkina I. S. Boksha 2003 Comparative study of creatine kinase BB decrease in brain of patients with Alzheimer's disease and schizophrenia T. Kekelidze D. Holtzman Creatine Kinase and Brain Energy Metabolism NATO Science Series 342 IOS Press Netherlands 125 132
27. S. David M. Shoemaker B. E. Haley 1998 Abnormal properties of creatine kinase in Alzheimer's disease brain: Correlation of reduced enzymatic activity and active site photolabeling with aberrant cytosol-membrane partitioning Mol. Brain Res. 54 276 287
28. I. S. Boksha 2004 Coupling between neuronal and glial cells via glutamate metabolism in brain of healthy persons and patients with mental disorders Biochemistry (Moscow) 69 7 705 719